Wegovy reviews after stopping: what people experience and what the evidence says

Step 1, the medicine clears and appetite comes back

Semaglutide has a half-life of roughly a week, meaning it takes several weeks to leave your system fully after your last injection. During that window, the appetite-suppressing effect fades gradually rather than switching off overnight. Most people describe the change as a slow reappearance of hunger: food becomes more appealing, portion sizes creep up, and the mental quietness around eating that many find so useful on treatment simply isn't there any more.

This is the pharmacology working as expected, not a withdrawal in the clinical sense. Semaglutide is not physically addictive, and there is no recognised discontinuation syndrome comparable to, say, stopping certain antidepressants. The discomfort people report is usually the return of the biological drivers that made weight management hard in the first place. Some people also notice their digestion shifting (constipation or looser stools briefly) as gut motility returns to its pre-treatment pace. For most, this settles within a few weeks.

A common misconception is that the body has been permanently reset and will simply stay at the new weight. It hasn't, and it won't without the continued signal. Understanding that before stopping tends to make the experience less disheartening.

Step 2, what the trial data actually shows about weight over time

The clearest evidence comes from the STEP 1 trial extension, which tracked participants for a year after they stopped semaglutide 2.4mg. On average, they regained around two-thirds of the weight lost during treatment, roughly 12 of the 17 percentage points of body weight they had shed. That is a consistent finding, and the NHS's patient guidance on semaglutide reflects this pattern directly: semaglutide is described as a long-term treatment, and stopping it means the effect stops too.

That said, 'average' conceals real variation. Some people in the extension data held more of their loss than the mean suggests, particularly those who had made lasting changes to food habits and physical activity during treatment. The medicine can be a useful window to build new patterns; the patterns matter more once it is gone. If you want to understand what that transition looks like in practice, our page on stopping Wegovy after reaching your weight loss goal walks through the key considerations honestly. Reviews from people who have stopped tend to split along this line, those who had built a sustainable routine fared better than those who had relied entirely on the appetite suppression.

If you are weighing up what stopping might mean for you, the detail on stopping Wegovy covers the process and the clinical considerations in full.

Step 3, what people actually say, and how that compares to the evidence

Online reviews and forum accounts after stopping Wegovy are worth reading with a little context. People who had a difficult experience (rapid regain, pronounced hunger, mood changes) are more likely to post than those whose transition was uneventful. That skews the impression you get from scrolling. The broader picture from Wegovy reviews across the treatment period shows that most side effects are front-loaded (strongest when starting or increasing dose) rather than at the end, and accounts from people on the introductory 0.5mg dose give a useful baseline for how the medicine feels before titration begins.

What does come through consistently in lived accounts is surprise at how quickly hunger returns and how sharply appetite differs from the treated state. People describe feeling as though a volume dial was turned back up. That matches the pharmacology. Less commonly reported but real for some: a sense of loss or frustration, particularly for those who had found the treatment transformative and were stopping due to cost or supply rather than choice.

For anyone considering stopping because of cost, it is worth reading about how Wegovy is priced privately before making a final call, sometimes a dose adjustment or a structured pause changes the calculation.

Step 4, planning a stop, and when to speak to someone

An abrupt stop is not dangerous in the way that stopping some medicines is, but it is rarely the best approach. A prescriber can help you think through whether tapering, a planned pause, or a switch to a lower maintenance dose makes more sense for your situation. If you stopped because the medicine stopped working, that is different from stopping because you have met your goal weight and want to trial life without it.

The guide to what happens after stopping Wegovy covers the practical steps in detail. If you are on a private prescription and want clinical support around a decision to stop, speaking to our prescribers is straightforward: consultations are free, reviewed the same day by a GPhC-registered Independent Prescriber, and there is no obligation to continue treatment. A prescriber at a service like ours also has access to the full picture of your treatment history, which makes the conversation more useful than a general GP appointment where the notes may be sparse. The MHRA's Yellow Card scheme is also there if you experience anything unexpected after stopping that you think should be formally reported.